JADPRO Live 2017 Activities
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
Narratives: HER2-Positive Breast Cancer
An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC
What is the current thinking on diagnosis and treatment of patients with squamous cell NSCLC?
Frank E. Mott
Melinda Oliver: How do you identify and manage adverse events?
Melinda Oliver: How do you interpret a patient’s therapeutic response to treatment?
Frank E. Mott: What are the genetic variants in NSCLC, and how are they used to select treatment?
Whitney Lewis: What are the mechanisms of action of targeted treatments and immunotherapies?
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.
Bot trap - Don't go here
to learn more.